We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Common, Rare and Somatic Genetic Drivers Together Double 5‑Year Atrial Fibrillation Risk: Toward an Integrated Genomic Model (IGM‑AF)

MedXY Editorial Team•Dec 3, 2025•Cardiology
atrial fibrillationClonal hematopoiesisgeneticspolygenic risk

Highlight

– Whole‑genome data from 416,085 UK Biobank participants show that polygenic risk, a composite rare‑variant gene set, and somatic clonal hematopoiesis (CHIP) each independently increase 5‑year incident atrial fibrillation (AF) risk.
– Individuals carrying all three genetic drivers had at least a two‑fold higher 5‑year AF cumulative incidence versus those with a single driver.
– Integrating the integrated genomic model for AF (IGM‑AF) with a clinical risk tool (CHARGE‑AF) raised the C‑statistic to 0.80 and produced a modest net reclassification improvement (NRI 0.08), supporting additive predictive value of comprehensive genomic profiling.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Stroke and Systemic Embolism Following Atrial Fibrillation Ablation: Insights from the EMBOL-AF Global Registry and Contemporary EvidenceThe EMBOL-AF Global Registry provides comprehensive data on stroke and systemic embolism post-atrial fibrillation ablation, highlighting incidence, timing, risk factors, and procedural impacts alongside evolving ablation strategies and longSep 27, 2026The ULYSSES Trial: Ultrasound Guidance Significantly Reduces Vascular Complications in Atrial Fibrillation AblationThe ULYSSES trial demonstrates that ultrasound-guided femoral venous puncture markedly lowers vascular access complications compared to conventional palpation-guided techniques in patients undergoing atrial fibrillation ablation, enhancingSep 25, 2026Cardiac Resynchronization Therapy With or Without Atrioventricular Node Ablation in Atrial Fibrillation: The CAAN-AF TrialThis trial evaluated whether atrioventricular node ablation improves outcomes of cardiac resynchronization therapy in heart failure patients with permanent atrial fibrillation, finding no significant benefit over medical rate control.Sep 25, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Genetically Mediated LDL Cholesterol Variations and Their Limited Impact on Venous Thromboembolism Risk
This study reveals that lifelong genetic differences in LDL cholesterol levels do not significantly affect the risk of venous thromboembolism (VTE), suggesting LDL-C may not be a major causal factor in VTE development.
Sep 25, 2026
Leveraging Proteomic Signatures of Clonal Hematopoiesis to Predict Outcomes in HFpEFThis study identifies plasma proteomic signatures linked to clonal hematopoiesis driver mutations and develops a proteomic risk score that independently predicts adverse clinical outcomes in heart failure with preserved ejection fraction (HSep 23, 2026
Breast Cancer-Derived ADAM10: A Novel Mediator of Atrial Fibrillation Through Atrial FibrosisBreast cancer independently increases atrial fibrillation risk via tumour-secreted ADAM10, which induces atrial fibrosis through the Ephrin B2 signaling pathway, offering a potential new therapeutic target.Sep 21, 2026